(Q38264545)

1 September 2017

1 reference

title

A review of emerging trends in the treatment of tuberculosis (English)

1 reference

1 September 2017

1 reference

Manpreet Kaur

1

1 reference

1 September 2017

Tarun Garg

series ordinal

2

1 reference

1 September 2017

R K Narang

series ordinal

3

1 reference

1 September 2017

publication date

3 November 2014

1 reference

Artificial cells, nanomedicine, and biotechnology

1 September 2017

published in

1 reference

1 September 2017

volume

44

1 reference

1 September 2017

issue

2

1 reference

1 September 2017

page(s)

478-484

1 reference

Inhalable alginate nanoparticles as antitubercular drug carriers against experimental tuberculosis

1 September 2017

cites work

1 reference

https://api.crossref.org/works/10.3109%2F21691401.2014.962745

Biological evaluation of pyrazinamide liposomes for treatment of Mycobacterium tuberculosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F21691401.2014.962745

The lectin-cell interaction and its implications to intestinal lectin-mediated drug delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F21691401.2014.962745

Chemotherapeutic potential of free and liposome encapsulated streptomycin against experimental Mycobacterium avium complex infections in beige mice

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F21691401.2014.962745

Inhaled large porous particles of capreomycin for treatment of tuberculosis in a guinea pig model

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F21691401.2014.962745

Current nanotechnological approaches for an effective delivery of bio-active drug molecules in the treatment of acne

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F21691401.2014.962745

Biomaterial-based scaffolds--current status and future directions

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F21691401.2014.962745

Scaffold: a novel carrier for cell and drug delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F21691401.2014.962745

Stimuli-sensitive hydrogels: an excellent carrier for drug and cell delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F21691401.2014.962745

The potential advantages of nanoparticle drug delivery systems in chemotherapy of tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F21691401.2014.962745

Current nanotechnological strategies for an effective delivery of drugs in treatment of periodontal disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F21691401.2014.962745

Advanced topical drug delivery system for the management of vaginal candidiasis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F21691401.2014.962745

Advanced drug delivery approaches against periodontitis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F21691401.2014.962745

Current nanotechnological strategies for effective delivery of bioactive drug molecules in the treatment of tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F21691401.2014.962745

Liposome-encapsulated-gentamicin therapy of Mycobacterium avium complex infection in beige mice

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F21691401.2014.962745

Poly (lactide-co-glycolide) microspheres in respirable sizes enhance an in vitro T cell response to recombinant Mycobacterium tuberculosis antigen 85B.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F21691401.2014.962745

Permeation enhancer strategies in transdermal drug delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F21691401.2014.962745

Antitubercular inhaled therapy: opportunities, progress and challenges

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F21691401.2014.962745

Solid lipid particle-based inhalable sustained drug delivery system against experimental tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F21691401.2014.962745

Poly (DL-lactide-co-glycolide) nanoparticle-based inhalable sustained drug delivery system for experimental tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F21691401.2014.962745

Oral solid lipid nanoparticle-based antitubercular chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F21691401.2014.962745

Alginate-based oral drug delivery system for tuberculosis: pharmacokinetics and therapeutic effects

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F21691401.2014.962745

Lectin-functionalized poly (lactide-co-glycolide) nanoparticles as oral/aerosolized antitubercular drug carriers for treatment of tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F21691401.2014.962745

Recent advances in polymeric electrospun nanofibers for drug delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F21691401.2014.962745

Respirable PLGA microspheres containing rifampicin for the treatment of tuberculosis: screening in an infectious disease model

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F21691401.2014.962745

Design of liposomal aerosols for improved delivery of rifampicin to alveolar macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F21691401.2014.962745

10.3109/21691401.2014.962745

21 January 2018

Identifiers

DOI

1 reference

1 September 2017

1 reference